United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 4 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Trulieve Cannabis Corp.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | |||
|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -6.2% | 2.31% | 1.88% | 1.56% | 1.77% |
|---|---|---|---|---|---|
| ROA | -4.39% | 2.25% | 1.74% | 1.37% | 1.47% |
| Gross Margin | 60.32% | 58.78% | 58.34% | 57.3% | 57.44% |
| Net Margin | -10.35% | 4.76% | 3.58% | 2.82% | 3.03% |
| Total Assets | $2,696,098.00K | $2,896,398.94K | $3,113,229.55K | $3,347,948.30K | $3,593,907.44K |
| Net Income | -$122,248.00K | $63,036.05K | $52,295.78K | $44,295.35K | $51,087.75K |